Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:521 (28 February), doi:10.1136/bmj.328.7438.521
| The first 100% of the full text of this article appears below. |
EDITORI agree with Law's view of screening, that screening of unproved value should not be advocated.1 As a clinical endocrinologist I often have to deal with patients' anxieties about non-palpable incidental findings on thyroid ultrasonography, often performed for wrong or unjustified reasons. Sometimes patients arrive with already established surgical complications after unnecessary thyroid operations.
Although a substantial number of incidental thyroid nodules may be histologically malignant,2 their clinical importance has never been proved. A recent preliminary study indicates that the progression rate of non-palpable proved thyroid malignant nodules to clinically significant lesions may be very low.3 Thyroid ultrasonography is an additional example of an often used, often non-efficacious screening modality that may lead to "cascade iatrogenesis."4
Yair Liel, head, endocrine service
Soroka University Medical Centre, Beer-Sheva, Israel liel@bgumail.bgu.ac.il